PMID-sentid	Pub_year	Sent_text	compound_name	comp_offset	prot_official_name	organism	prot_offset
12906929-3	2003	In perfused rat livers, the thromboxane receptor antagonist daltroban enhanced C5a-induced prostanoid overflow and reduced glucose output.	daltroban	60-69	complement C5	Rattus norvegicus	79-82
12906929-5	2003	In perfused rat livers, daltroban enhanced prostaglandin (PG)D(2) overflow not only after infusion of C5a (15-fold), but also after PGD(2) (10-fold).	daltroban	24-33	complement C5	Rattus norvegicus	102-105
11163769-1	2001	The role of K396 in the enzymatic catalysis and the antigenicity of the 65 kDa isoform of glutamate decarboxylase (GAD65) was analyzed using the K396R GAD65 mutant.	daltroban	12-16	glutamate-ammonia ligase	Homo sapiens	90-113
11163769-1	2001	The role of K396 in the enzymatic catalysis and the antigenicity of the 65 kDa isoform of glutamate decarboxylase (GAD65) was analyzed using the K396R GAD65 mutant.	daltroban	12-16	glutamate decarboxylase 2	Homo sapiens	115-120
10799912-7	2000	In perfused livers of IL-6-treated animals in contrast to control animals, recombinant rat C5a-induced glucose output was not impaired by inhibition of prostanoid synthesis and function with the cyclooxygenase inhibitor indomethacin and the thromboxane receptor antagonist daltroban.	daltroban	273-282	complement C5	Rattus norvegicus	91-94
10344349-2	1999	We have shown previously that the administration of daltroban, a specific thromboxane receptor antagonist, prevented hypertension in ADRP rats.	daltroban	52-61	perilipin 2	Rattus norvegicus	133-137
7771545-5	1995	The increased vascular resistance caused by PAF alone was significantly attenuated by ibuprofen, BM-13505, and dexamethasone.	daltroban	97-105	PCNA clamp associated factor	Rattus norvegicus	44-47
1516634-4	1992	Pretreatment of the animals with BM-13505 (1 mg/kg), a thromboxane A2 (TxA2) receptor antagonist, prolonged the duration of the hypotensive response to ET-1 (1.0 nmol/kg) but had no effect on the pressor response.	daltroban	33-41	thromboxane A2 receptor	Rattus norvegicus	55-85
1516634-4	1992	Pretreatment of the animals with BM-13505 (1 mg/kg), a thromboxane A2 (TxA2) receptor antagonist, prolonged the duration of the hypotensive response to ET-1 (1.0 nmol/kg) but had no effect on the pressor response.	daltroban	33-41	endothelin 1	Rattus norvegicus	152-156
1632287-0	1992	Effects of daltroban, a thromboxane (TX) A2 receptor antagonist, on lipid metabolism and atherosclerosis.	daltroban	11-20	thromboxane A2 receptor	Rattus norvegicus	24-52
1833368-3	1991	Airway responses to ET-1 were decreased significantly by sodium meclofenamate, a cyclooxygenase inhibitor, and by SKF 96148, a thromboxane receptor blocking agent.	daltroban	114-123	endothelin 1	Felis catus	20-24
2151550-0	1990	Investigations of the antiatherosclerotic effect of the thromboxane A2 receptor antagonist Daltroban.	daltroban	91-100	TBXA2R	Oryctolagus cuniculus	56-79
33610008-3	2021	In contrast, injection of the TxA2-R antagonist daltroban (80 mug) into the arterial supply of the hindlimb reduced the pressor response to dynamic hindlimb muscle stretch in HF-rEF (n = 11, peak  MAP pre: 28 +- 4; post: 16 +- 2 mm Hg; P = 0.02) but not sham (n = 8, peak  MAP pre: 17 +- 3; post: 16 +- 3; P = 0.84) rats.	daltroban	48-57	thromboxane A2 receptor	Rattus norvegicus	30-36
32954541-6	2020	We hypothesized that injection of either the EP4-R antagonist L-161,982 (1 mug) or the TxA2 -R antagonist daltroban (80 mug) into the arterial supply of the hindlimb would reduce the increase in blood pressure and renal sympathetic nerve activity (RSNA) evoked in response to 30 s of static hindlimb skeletal muscle stretch (a model of isolated mechanoreflex activation) in decerebrate, unanesthetized HF-rEF rats but not sham operated control rats (SHAM).	daltroban	106-115	thromboxane A2 receptor	Rattus norvegicus	87-94
32530751-4	2020	We hypothesized that injection of the endoperoxide 4 receptor (EP4-R) antagonist L161982 or the thromboxane A2 receptor (TxA2-R) antagonist daltroban into the arterial supply of the hindlimb would reduce the pressor response to repetitive, dynamic hindlimb skeletal muscle stretch (a model of isolated mechanoreflex activation) in rats with a femoral artery that was ligated ~72 hours before the experiment but not in rats with freely perfused femoral arteries.	daltroban	140-149	thromboxane A2 receptor	Rattus norvegicus	96-119
32530751-4	2020	We hypothesized that injection of the endoperoxide 4 receptor (EP4-R) antagonist L161982 or the thromboxane A2 receptor (TxA2-R) antagonist daltroban into the arterial supply of the hindlimb would reduce the pressor response to repetitive, dynamic hindlimb skeletal muscle stretch (a model of isolated mechanoreflex activation) in rats with a femoral artery that was ligated ~72 hours before the experiment but not in rats with freely perfused femoral arteries.	daltroban	140-149	thromboxane A2 receptor	Rattus norvegicus	121-127